Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_provenance.
- NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_assertion description "[Consistently, overexpression of ADAR and ADARB1 in the U87 glioblastoma multiforme cell line resulted in decreased proliferation rate, suggesting that reduced A-to-I editing in brain tumors is involved in the pathogenesis of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_provenance.
- NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_assertion evidence source_evidence_literature NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_provenance.
- NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_assertion SIO_000772 17908822 NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_provenance.
- NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_assertion wasDerivedFrom befree-20140225 NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_provenance.
- NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_assertion wasGeneratedBy ECO_0000203 NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP174561.RA2trjO2CjQnJcEW3FgH-IK2Y-FrfuYiJQ9_LBoSnLVpM130_provenance.